Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;17(4):451-455.
doi: 10.1111/vco.12518. Epub 2019 Jul 9.

Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group

Douglas H Thamm  1 , Anne C Avery  1 , Davide Berlato  2 , Julie Bulman-Fleming  3 , Craig A Clifford  4 , A Elizabeth Hershey  5 , Joanne L Intile  6 , Pamela D Jones  7 , Debra A Kamstock  8 , Julius M Liptak  9 , Alana Pavuk  10 , John Peauroi  11 , Roger Powell  12 , Kerry Rissetto  13 , Victor E O Valli  11 , Joshua D Webster  14
Affiliations
Review

Prognostic and predictive significance of KIT protein expression and c-kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology-Pathology Working Group

Douglas H Thamm et al. Vet Comp Oncol. 2019 Dec.

Abstract

One of the primary objectives of the Oncology-Pathology Working Group (OPWG), a joint initiative of the Veterinary Cancer Society and the American College of Veterinary Pathologists, is for oncologists and pathologists to collaboratively generate consensus documents to standardize aspects of and provide guidelines for oncologic pathology. Consensus is established through critical review of peer-reviewed literature relevant to a subgroup's particular focus. Subsequent acceptance and approval of the document by the OPWG membership at large establishes consensus. The intent of this publication is to help educate practitioners and pathologists on the value of diagnostics related to the KIT receptor tyrosine kinase for canine cutaneous mast cell tumours and to provide a guide for the use of these tests in veterinary medicine. This document represents the opinions of the OPWG and the authors and does not constitute a formal endorsement by the American College of Veterinary Pathologists or the Veterinary Cancer Society.

Keywords: cancer; dog; immunohistochemistry; kinase; mutation.

PubMed Disclaimer

References

REFERENCES

    1. Bostock DE. Neoplasms of the skin and subcutaneous tissues in dogs and cats. Br Vet J. 1986;142(1):1-19.*
    1. Brodey RS. Canine and feline neoplasia. Adv Vet Sci Comp Med. 1970;14:309-354.*
    1. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol. 1984;21(5):469-474.*
    1. Kiupel M, Webster JD, Bailey KL, et al. Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior. Vet Pathol. 2011;48(1):147-155.*
    1. Letard S, Yang Y, Hanssens K, et al. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors. Mol Cancer Res. 2008;6(7):1137-1145.

MeSH terms

Substances

LinkOut - more resources